Eu Ivdd Eu Ivd General On The Market 🇫🇮 Finland

Pepsinogen I

Biohit Oyj · 🇫🇮 Finland
Devices (same UDI-DI)
1
Certificates
0
Countries
0
Notified Bodies
0

Basic Information

Primary DI
06419587010106
Basic UDI-DI Code
B-06419587010106
Reference
601010.01
Device Types
Single use
Regulation
Eu Ivdd
Classification
Eu Ivd General
Status
On The Market
Manufacturer
Biohit Oyj

Additional Description

Pepsinogen I (PGI) test is an in vitro microplate-based quantitative enzyme-linked immunosorbent assay (ELISA) for the determination of human pepsinogen I from EDTA plasma or serum samples. The test aids in diagnosis of an advanced atrophic gastritis in the gastric corpus from the patients at risk to develop malignant cellular changes in stomach mucosa. In addition, it aids in screening conditions that necessitate additional examination or treatment from healthy stomach mucosa. Pepsinogen I test can also be used together with the Pepsinogen II test (REF 601020.02) by which the PGI/PGII ratio is determined. The test can be conducted either manually or automatically and is to be used by healthcare professionals.

CND Nomenclature Codes

Code Description
W0102019099 SPECIFIC PROTEINS - OTHER

Similar Devices

Other on-the-market devices with the same classification (Eu Ivd General) and regulation (EU IVDD).

View all